table of content
1 Study Coverage
1.1 Sulphonamides Product Introduction
1.2 Global Sulphonamides Outlook 2017 VS 2022 VS 2028
1.2.1 Global Sulphonamides Sales in US$ Million for the Year 2017-2028
1.2.2 Global Sulphonamides Sales in Volume for the Year 2017-2028
1.3 United States Sulphonamides Outlook 2017 VS 2022 VS 2028
1.3.1 United States Sulphonamides Sales in US$ Million for the Year 2017-2028
1.3.2 United States Sulphonamides Sales in Volume for the Year 2017-2028
1.4 Sulphonamides Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Sulphonamides in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Sulphonamides Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Sulphonamides Market Dynamics
1.5.1 Sulphonamides Industry Trends
1.5.2 Sulphonamides Market Drivers
1.5.3 Sulphonamides Market Challenges
1.5.4 Sulphonamides Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Sulphonamides Market Segment by Type
2.1.1 Orally Absorbable Sulfonamide
2.1.2 Orally Non Absorbable Sulfonamide (sulfasalzine, osalazine)
2.1.3 Topical Agents (Silver sulfadiazine, sulfacetamide, mafenide)
2.2 Global Sulphonamides Market Size by Type
2.2.1 Global Sulphonamides Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Sulphonamides Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Sulphonamides Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Sulphonamides Market Size by Type
2.3.1 United States Sulphonamides Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Sulphonamides Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Sulphonamides Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Sulphonamides Market Segment by Application
3.1.1 Skin Infections
3.1.2 Gastro Intestinal Tract (GIT) Infection
3.1.3 Meningitis
3.2 Global Sulphonamides Market Size by Application
3.2.1 Global Sulphonamides Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Sulphonamides Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Sulphonamides Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Sulphonamides Market Size by Application
3.3.1 United States Sulphonamides Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Sulphonamides Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Sulphonamides Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Sulphonamides Competitor Landscape by Company
4.1 Global Sulphonamides Market Size by Company
4.1.1 Top Global Sulphonamides Manufacturers Ranked by Revenue (2021)
4.1.2 Global Sulphonamides Revenue by Manufacturer (2017-2022)
4.1.3 Global Sulphonamides Sales by Manufacturer (2017-2022)
4.1.4 Global Sulphonamides Price by Manufacturer (2017-2022)
4.2 Global Sulphonamides Concentration Ratio (CR)
4.2.1 Sulphonamides Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Sulphonamides in 2021
4.2.3 Global Sulphonamides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Sulphonamides Manufacturing Base Distribution, Product Type
4.3.1 Global Sulphonamides Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Sulphonamides Product Type
4.3.3 Date of International Manufacturers Enter into Sulphonamides Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Sulphonamides Market Size by Company
4.5.1 Top Sulphonamides Players in United States, Ranked by Revenue (2021)
4.5.2 United States Sulphonamides Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Sulphonamides Sales by Players (2020, 2021 & 2022)
5 Global Sulphonamides Market Size by Region
5.1 Global Sulphonamides Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Sulphonamides Market Size in Volume by Region (2017-2028)
5.2.1 Global Sulphonamides Sales in Volume by Region: 2017-2022
5.2.2 Global Sulphonamides Sales in Volume Forecast by Region (2023-2028)
5.3 Global Sulphonamides Market Size in Value by Region (2017-2028)
5.3.1 Global Sulphonamides Sales in Value by Region: 2017-2022
5.3.2 Global Sulphonamides Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Sulphonamides Market Size YoY Growth 2017-2028
6.1.2 North America Sulphonamides Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Sulphonamides Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Sulphonamides Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Sulphonamides Market Size YoY Growth 2017-2028
6.3.2 Europe Sulphonamides Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Sulphonamides Market Size YoY Growth 2017-2028
6.4.2 Latin America Sulphonamides Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Sulphonamides Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Sulphonamides Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporation Information
7.1.2 Abbott Laboratories Description and Business Overview
7.1.3 Abbott Laboratories Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Abbott Laboratories Sulphonamides Products Offered
7.1.5 Abbott Laboratories Recent Development
7.2 Boehringer Ingelheim Pharmaceuticals
7.2.1 Boehringer Ingelheim Pharmaceuticals Corporation Information
7.2.2 Boehringer Ingelheim Pharmaceuticals Description and Business Overview
7.2.3 Boehringer Ingelheim Pharmaceuticals Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Boehringer Ingelheim Pharmaceuticals Sulphonamides Products Offered
7.2.5 Boehringer Ingelheim Pharmaceuticals Recent Development
7.3 Bayer AG
7.3.1 Bayer AG Corporation Information
7.3.2 Bayer AG Description and Business Overview
7.3.3 Bayer AG Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Bayer AG Sulphonamides Products Offered
7.3.5 Bayer AG Recent Development
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporation Information
7.4.2 GlaxoSmithKline Description and Business Overview
7.4.3 GlaxoSmithKline Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.4.4 GlaxoSmithKline Sulphonamides Products Offered
7.4.5 GlaxoSmithKline Recent Development
7.5 King Pharmaceuticals
7.5.1 King Pharmaceuticals Corporation Information
7.5.2 King Pharmaceuticals Description and Business Overview
7.5.3 King Pharmaceuticals Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.5.4 King Pharmaceuticals Sulphonamides Products Offered
7.5.5 King Pharmaceuticals Recent Development
7.6 Mylan Pharmaceuticals
7.6.1 Mylan Pharmaceuticals Corporation Information
7.6.2 Mylan Pharmaceuticals Description and Business Overview
7.6.3 Mylan Pharmaceuticals Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Mylan Pharmaceuticals Sulphonamides Products Offered
7.6.5 Mylan Pharmaceuticals Recent Development
7.7 Novartis International AG
7.7.1 Novartis International AG Corporation Information
7.7.2 Novartis International AG Description and Business Overview
7.7.3 Novartis International AG Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Novartis International AG Sulphonamides Products Offered
7.7.5 Novartis International AG Recent Development
7.8 Pfizer
7.8.1 Pfizer Corporation Information
7.8.2 Pfizer Description and Business Overview
7.8.3 Pfizer Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Pfizer Sulphonamides Products Offered
7.8.5 Pfizer Recent Development
7.9 Par Pharmaceutical
7.9.1 Par Pharmaceutical Corporation Information
7.9.2 Par Pharmaceutical Description and Business Overview
7.9.3 Par Pharmaceutical Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Par Pharmaceutical Sulphonamides Products Offered
7.9.5 Par Pharmaceutical Recent Development
7.10 Roche Holding AG
7.10.1 Roche Holding AG Corporation Information
7.10.2 Roche Holding AG Description and Business Overview
7.10.3 Roche Holding AG Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Roche Holding AG Sulphonamides Products Offered
7.10.5 Roche Holding AG Recent Development
7.11 Sanofi Aventis
7.11.1 Sanofi Aventis Corporation Information
7.11.2 Sanofi Aventis Description and Business Overview
7.11.3 Sanofi Aventis Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Sanofi Aventis Sulphonamides Products Offered
7.11.5 Sanofi Aventis Recent Development
7.12 Stiefel Laboratories
7.12.1 Stiefel Laboratories Corporation Information
7.12.2 Stiefel Laboratories Description and Business Overview
7.12.3 Stiefel Laboratories Sulphonamides Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Stiefel Laboratories Products Offered
7.12.5 Stiefel Laboratories Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Sulphonamides Industry Chain Analysis
8.2 Sulphonamides Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Sulphonamides Distributors
8.3 Sulphonamides Production Mode & Process
8.4 Sulphonamides Sales and Marketing
8.4.1 Sulphonamides Sales Channels
8.4.2 Sulphonamides Distributors
8.5 Sulphonamides Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
